RYTM
Rhythm Pharmaceuticals Inc
$59.03
Earnings Summary
Revenue | $33.25Mn |
Net Profits | $-44.97Mn |
Net Profit Margins | -135.24% |
Highlights
Rhythm Pharmaceuticals Inc’s revenue jumped 47.76% since last year same period to $33.25Mn in the Q3 2024. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 14.35% jump in its revenue since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit fell -1.83% since last year same period to $-44.97Mn in the Q3 2024. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -39.39% fall in its net profits since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit margin jumped 31.08% since last year same period to -135.24% in the Q3 2024. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -21.9% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Rhythm Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Year | -2.16 |
Highlights
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -2.16.
Key Ratios
Key ratios of the Rhythm Pharmaceuticals Inc post its Q3 2024 earnings
Earning Per Share (EPS) | -0.73 |
Highlights
Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 3.95% since last year same period to -0.73 in the Q3 2024. This indicates that the Rhythm Pharmaceuticals Inc has generated 3.95% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-07 | -2.16 | -2.35 | -8.8% |
2024-11-06 | -0.8 | -0.73 | 8.75% |
2024-08-14 | -0.71 | -0.69 | 2.82% |
₹0 US Stocks a/c Opening Fee